22 Sept 2023
According to a study published in Diabetes Technology & Therapeutics, patients with type 1 diabetes who were part of the iLet bionic pancreas trial reported less diabetes distress and fear levels of hypoglycemia fear than patients receiving the standard of care. Children reported the most benefits.